Structure Therapeutics Inc. Active Patents
15 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-03-18: Application 19083274; Invention HETEROCYCLIC GLP-1 AGONISTS; Applicant Gasherbrum Bio, Inc.; Status Patented Case.
- 2025-03-07: Application 19074260; Invention COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/; Applicant Aconcagua Bio, Inc.; Status Patented Case.
- 2024-07-02: Application 18762532; Invention HETEROCYCLIC GLP-1 AGONISTS; Applicant Gasherbrum Bio, Inc.; Status Patented Case.
- 2024-01-26: Application 18424580; Invention HETEROCYCLIC GLP-1 AGONISTS; Applicant Gasherbrum Bio, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 19083274 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2026-02-17 | 12552791 | US20250214999A1 | Qinghua MENG Andrew JENNINGS Hui LEI Xichen LIN | China China China China | HABTE, KAHSAY |
| 2025-03-07 | 19074260 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/ | Aconcagua Bio, Inc. | Patented Case | 2025-12-02 | 12486269 | US20250257067A1 | Hui LEI Cui LI Chunliang LU Ding XUE Haizhen ZHANG Zhuming ZHANG Jian LIU Zhe NIE Anatoly RUVINSKY Eric THERRIEN Evelyne HOUANG | China China China China China China United States United States United States United States United States | DRAPER, LESLIE A ROYDS |
| 2024-07-02 | 18762532 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2025-05-06 | 12291529 | US20240376105A1 | Wei HUANG Hui LEI Chunliang LU Haizhen ZHANG | China China China China | AULAKH, CHARANJIT |
| 2024-01-26 | 18424580 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2025-02-11 | 12221442 | US20240246962A1 | Qinghua MENG Weiqiang XING Haizhen ZHANG Xichen LIN Hui LEI Andrew JENNINGS | China China China China China United States | RAHMANI, NILOOFAR |
| 2023-12-08 | 18534520 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY | Lhotse Bio, Inc. | Patented Case | 2025-09-30 | 12428375 | US20240376054A1 | Wei HUANG Hui Lei Zhongmiao Xu Haizhen Zhang Qiong Zhang | China China China China China | HABTE, KAHSAY |
| 2023-12-08 | 18534517 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2026-01-20 | 12528781 | US20240376061A1 | Qinghua Meng Hui Lei Haizhen Zhang Xichen Lin Andrew Jennings | China China China China United States | BARSKY, JARED |
| 2023-05-23 | 18322492 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY | Lhotse Bio, Inc. | Patented Case | 2024-01-30 | 11884627 | US20230322675A1 | Wei Huang Hui Lei Zhongmiao Xu Haizhen Zhang Qiong Zhang | China China China China China | HABTE, KAHSAY |
| 2023-03-09 | 18044743 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2026-04-07 | 12595264 | US20230331732A1 | Qinghua MENG Weiqiang XING Haizhen ZHANG Xichen LIN Hui LEI Andrew JENNINGS | China China China China China United States | ROZOF, TIMOTHY R |
| 2023-02-06 | 18106378 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2024-02-13 | 11897851 | US20230192633A1 | Qinghua Meng Hui Lei Haizhen Zhang Xichen Lin Andrew Jennings | China China China China United States | BARSKY, JARED |
| 2022-09-21 | 17950073 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2024-03-12 | 11926626 | US20230107793A1 | Qinghua MENG Weiqiang XING Haizhen ZHANG Xichen LIN Hui LEI Andrew JENNINGS | China China China China China United States | RAHMANI, NILOOFAR |
| 2022-07-13 | 17864326 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | Annapurna Bio, Inc. | Patented Case | 2024-04-02 | 11944622 | US20230165854A1 | Haifeng Tang Michael Hanson Sarah Boyce Zhe Nie | United States United States United States United States | RAHMANI, NILOOFAR |
| 2022-06-29 | 17853755 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2024-03-12 | 11926643 | US20230174565A1 | Qinghua MENG Xichen LIN Haizhen ZHANG Weiqiang XING Hui LEI Andrew JENNINGS | China China China China China United States | O DELL, DAVID K |
| 2022-01-10 | 17572531 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | Annapurna Bio, Inc. | Patented Case | 2022-10-18 | 11471455 | US20220125787A1 | Haifeng Tang Michael Hanson Sarah Boyce Zhe Nie | United States United States United States United States | RAHMANI, NILOOFAR |
| 2022-01-07 | 17571351 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. | Patented Case | 2022-11-08 | 11492365 | US20220213130A1 | Qinghua Meng Xichen Lin Haizhen Zhang Hui Lei Andrew Jennings | China China China China United States | O DELL, DAVID K |
| 2020-08-19 | 16971227 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | Annapurna Bio, Inc. | Patented Case | 2023-08-15 | 11724997 | US20210053936A1 | Haifeng Tang Sarah Boyce Michael Hanson Zhe Nie | United States United States United States United States | CHANDRAKUMAR, NIZAL S |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |